Cognitive Impairment and Agent Orange Exposure in Veterans with Essential Tremor.
Objective: The objective of this study is to determine differences in cognitive profiles among Veterans with Essential Tremor (ET) who were exposed to agent orange…Investigation of Sex-based Differences in the Utility of IgG Index as a Potential Predictor of Cognitive Impairment in Parkinson’s Disease
Objective: Determine if there are sex-based differences in associations of baseline (BL) immunoglobulin G (IgG) index with development of cognitive impairment (CI) among cognitively normal…Executive Dysfunction as a Determinant of Functional Impairment in Parkinson’s Disease
Objective: To evaluate executive function across cognitive stages of Parkinson’s disease and examine its association with functional impairment. Background: Executive dysfunction is one of the…Biofluid Markers in Parkinson’s Patients and Correlation with Cognitive Profile
Objective: The purpose of this study was to determine potential biofluid biomarkers for cognitive impairment in a cohort of Parkinson's disease (PD) patients. Here we…Cognitive profiles in idiopathic normal pressure hydrocephalus: clinical patterns and the impact of coexisting neurodegeneration
Objective: To characterise cognitive severity and domain-specific profiles in patients with idiopathic normal pressure hydrocephalus (iNPH) and to examine the impact of coexisting neurodegeneration. Background:…Serum Based biomarkers in Parkinson’s disease with and without cognitive deficits.
Objective: To examine levels of putative biomarker proteins viz., neuronal pentraxin receptor (NPTXR), carnosine dipeptidase-1 (CNDP1), dickkopf-3 (DKK3) in the serum of Parkinson’s Disease patients…Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1-associated Parkinson’s Disease
Objective: This study focuses on the timing of DBS in relation to PD onset and explores cognitive trajectories across different GBA1 variant classes, with a…Longitudinal Association Between Baseline CSF GFAP Levels and Clinical Progression in Parkinson’s Disease A PPMI Study
Objective: To investigate whether baseline cerebrospinal fluid (CSF) glial fibrillary acidic protein (GFAP) levels predict changes in cognitive performance (MOCA) and motor severity (UPDRS) over…Circadian Regulator REV-ERBα Drives Microglial Lipid Metabolic Reprogramming and Cognitive Impairment in Parkinson‘s Disease
Objective: To investigate the mechanisms by which sleep disturbance exacerbates motor and cognitive deficits in Parkinson’s disease (PD), and to determine how alterations in the…Can digital Mobility Outcomes differentiate cognitive impairment in Parkinson’s Disease?
Objective: To determine if digital mobility outcomes (DMOs) differentiate between those with and without cognitive impairment in Parkinson’s disease (PD). Background: Cognitive impairment is common…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.